Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocyt

Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocyt

Item

http://www.wikidata.org/entity/Q42375787

Q42375787

about

Pathophysiology of Pediatric Multiple Organ Dysfunction Syndrome.An expanding role for interleukin-1 blockade from gout to cancer.How We Manage Hyperferritinemic Sepsis-Related Multiple Organ Dysfunction Syndrome/Macrophage Activation Syndrome/Secondary Hemophagocytic Lymphohistiocytosis Histiocytosis.Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial.Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets?Interleukin 1 Receptor Antagonist Anakinra, Intravenous Immunoglobulin, and Corticosteroids in the Management of Critically Ill Adult Patients With Hemophagocytic Lymphohistiocytosis.Epstein-Barr Virus and Hemophagocytic Lymphohistiocytosis.

P2860

Q33439759-5CE54859-D481-475E-8A15-AD77A062DDB2 Q35219001-E04EE899-FFE0-4580-8AEE-A505CC525226 Q37387929-C392D854-5D35-45D4-B2B7-C9CA8E0CB942 Q37735696-3E53FFD7-868D-4106-80D1-00FF89ED5680 Q38637780-4666AD78-7076-4300-98F8-7861B2F48CA3 Q39599766-984F03C4-1925-49A3-9DD3-EB57A93F1F1B Q47550133-5277EE29-5A0F-4A71-BFAD-2540924D6E7E

P2860

Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocyt

Item

http://www.wikidata.org/entity/Q42375787

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Plasma exchange, methylprednis ...... yndrome/secondary hemophagocyt

@en

Plasma exchange, methylprednis ...... yndrome/secondary hemophagocyt

@nl

type

Item

label

Plasma exchange, methylprednis ...... yndrome/secondary hemophagocyt

@en

Plasma exchange, methylprednis ...... yndrome/secondary hemophagocyt

@nl

prefLabel

Plasma exchange, methylprednis ...... yndrome/secondary hemophagocyt

@en

Plasma exchange, methylprednis ...... yndrome/secondary hemophagocyt

@nl

P1476

Plasma exchange, methylprednis ...... lymphohistiocytosis syndrome*

@en

P2093

Dennis W Simon

http://www.w3.org/2001/XMLSchema#string

Joseph A Carcillo

http://www.w3.org/2001/XMLSchema#string

Rajesh Aneja

http://www.w3.org/2001/XMLSchema#string

P2860

Successful treatment of non-familial haemophagocytic lymphohistiocytosis with interferon and gammaglobulin.

The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome

Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice.

Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?

Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells.

A critical role of CpG motifs in a murine peritonitis model by their binding to highly expressed toll-like receptor-9 on liver NKT cells.

Refractory macrophage activation syndrome in a patient with SLE and APLA syndrome - Successful use of PET- CT and Anakinra in its diagnosis and treatment.

Cytokine release syndrome after blinatumomab treatment related to abnormal macrophage activation and ameliorated with cytokine-directed therapy.

Secondary hemophagocytic lymphohistiocytosis and severe sepsis/ systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation.

A case of macrophage activation syndrome successfully treated with anakinra.

P304

486-488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1097/PCC.0000000000000098

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

E. Scott Halstead

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24892479

http://www.w3.org/2001/XMLSchema#string

P921

sepsis

P932

5091288

http://www.w3.org/2001/XMLSchema#string

Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocyt

about

P2860

P2860

Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome/secondary hemophagocyt

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932